To date, simple skin testing using recall antigens has proven to be the most accurate method of assessing preoperative risk for serious infectious complications. When used in conjunction with measures to control the microorganisms and the environment, evaluation of host defense mechanisms with skin testing can aid in reducing postoperative infectious morbidity and mortality.There are 3 possible therapeutic approaches to anergie patients. Surgery and specific nonsurgical treatments (restoration of blood volume, red cell mass, antibiotics), total parenteral nutrition, and immunorestoration. The challenge for the future is to develop the criteria that will indicate the most important defects which account for the anergic state in individual patients.